Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema

Identifieur interne : 00A896 ( Main/Exploration ); précédent : 00A895; suivant : 00A897

Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema

Auteurs : M. J. Karkkainen [Finlande] ; R. E. Ferrell [États-Unis] ; E. C. Lawrence [États-Unis] ; M. A. Kimak [États-Unis] ; K. L. Levinson [États-Unis] ; M. A. Mctigue [États-Unis] ; Kari Alitalo [Finlande] ; D. N. Finegold [États-Unis]

Source :

RBID : Pascal:00-0306799

Descripteurs français

English descriptors

Abstract

Primary lymphoedema is a rare, autosomal dominant disorder that leads to a disabling and disfiguring swelling of the extremities and, when untreated, tends to worsen with time. Here we link primary human lymphoedema to the FLT4 locus, encoding vascular endothelial growth factor receptor-3 (VEGFR-3), in several families. All disease-associated alleles analysed had missense mutations and encoded proteins with an inactive tyrosine kinase, preventing downstream gene activation. Our study establishes that VEGFR-3 is important for normal lymphatic vascular function and that mutations interfering with VEGFR-3 signal transduction are a cause of primary lymphoedema.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema</title>
<author>
<name sortKey="Karkkainen, M J" sort="Karkkainen, M J" uniqKey="Karkkainen M" first="M. J." last="Karkkainen">M. J. Karkkainen</name>
<affiliation wicri:level="4">
<inist:fA14 i1="01">
<s1>Molecular/Cancer Biology Laboratory, Ludwig Institute for Cancer Research, Huartman Institute, University of Helsinki</s1>
<s2>Helsinki</s2>
<s3>FIN</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Finlande</country>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
<orgName type="university">Université d'Helsinki</orgName>
</affiliation>
</author>
<author>
<name sortKey="Ferrell, R E" sort="Ferrell, R E" uniqKey="Ferrell R" first="R. E." last="Ferrell">R. E. Ferrell</name>
<affiliation wicri:level="4">
<inist:fA14 i1="02">
<s1>Department of Human Genetics, University of Pittsburgh</s1>
<s2>Pittsburgh, Penusylvania</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Pittsburgh</settlement>
<region type="state">Pennsylvanie</region>
</placeName>
<orgName type="university">Université de Pittsburgh</orgName>
</affiliation>
</author>
<author>
<name sortKey="Lawrence, E C" sort="Lawrence, E C" uniqKey="Lawrence E" first="E. C." last="Lawrence">E. C. Lawrence</name>
<affiliation wicri:level="4">
<inist:fA14 i1="02">
<s1>Department of Human Genetics, University of Pittsburgh</s1>
<s2>Pittsburgh, Penusylvania</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Pittsburgh</settlement>
<region type="state">Pennsylvanie</region>
</placeName>
<orgName type="university">Université de Pittsburgh</orgName>
</affiliation>
</author>
<author>
<name sortKey="Kimak, M A" sort="Kimak, M A" uniqKey="Kimak M" first="M. A." last="Kimak">M. A. Kimak</name>
<affiliation wicri:level="4">
<inist:fA14 i1="02">
<s1>Department of Human Genetics, University of Pittsburgh</s1>
<s2>Pittsburgh, Penusylvania</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Pittsburgh</settlement>
<region type="state">Pennsylvanie</region>
</placeName>
<orgName type="university">Université de Pittsburgh</orgName>
</affiliation>
</author>
<author>
<name sortKey="Levinson, K L" sort="Levinson, K L" uniqKey="Levinson K" first="K. L." last="Levinson">K. L. Levinson</name>
<affiliation wicri:level="4">
<inist:fA14 i1="02">
<s1>Department of Human Genetics, University of Pittsburgh</s1>
<s2>Pittsburgh, Penusylvania</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Pittsburgh</settlement>
<region type="state">Pennsylvanie</region>
</placeName>
<orgName type="university">Université de Pittsburgh</orgName>
</affiliation>
</author>
<author>
<name sortKey="Mctigue, M A" sort="Mctigue, M A" uniqKey="Mctigue M" first="M. A." last="Mctigue">M. A. Mctigue</name>
<affiliation wicri:level="2">
<inist:fA14 i1="03">
<s1>Agouron Pharmaceuticals, Inc.</s1>
<s2>San Diego, California</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Alitalo, K" sort="Alitalo, K" uniqKey="Alitalo K" first="K." last="Alitalo">Kari Alitalo</name>
<affiliation wicri:level="4">
<inist:fA14 i1="01">
<s1>Molecular/Cancer Biology Laboratory, Ludwig Institute for Cancer Research, Huartman Institute, University of Helsinki</s1>
<s2>Helsinki</s2>
<s3>FIN</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Finlande</country>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
<orgName type="university">Université d'Helsinki</orgName>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
<orgName type="university">Université d'Helsinki</orgName>
</affiliation>
</author>
<author>
<name sortKey="Finegold, D N" sort="Finegold, D N" uniqKey="Finegold D" first="D. N." last="Finegold">D. N. Finegold</name>
<affiliation wicri:level="4">
<inist:fA14 i1="02">
<s1>Department of Human Genetics, University of Pittsburgh</s1>
<s2>Pittsburgh, Penusylvania</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Pittsburgh</settlement>
<region type="state">Pennsylvanie</region>
</placeName>
<orgName type="university">Université de Pittsburgh</orgName>
</affiliation>
<affiliation wicri:level="4">
<inist:fA14 i1="04">
<s1>Department of Pediatrics, University of Pittsburgh</s1>
<s2>Pittsburgh, Penusylvania</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Pittsburgh</settlement>
<region type="state">Pennsylvanie</region>
</placeName>
<orgName type="university">Université de Pittsburgh</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">00-0306799</idno>
<date when="2000">2000</date>
<idno type="stanalyst">PASCAL 00-0306799 INIST</idno>
<idno type="RBID">Pascal:00-0306799</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000935</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000025</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000906</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000906</idno>
<idno type="wicri:doubleKey">1061-4036:2000:Karkkainen M:missense:mutations:interfere</idno>
<idno type="wicri:Area/Main/Merge">00AE37</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:10835628</idno>
<idno type="wicri:Area/PubMed/Corpus">004A66</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004A66</idno>
<idno type="wicri:Area/PubMed/Curation">004A66</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004A66</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004A66</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004A66</idno>
<idno type="wicri:Area/Ncbi/Merge">000341</idno>
<idno type="wicri:Area/Ncbi/Curation">000341</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000341</idno>
<idno type="wicri:doubleKey">1061-4036:2000:Karkkainen M:missense:mutations:interfere</idno>
<idno type="wicri:Area/Main/Merge">00A717</idno>
<idno type="wicri:Area/Main/Curation">00A896</idno>
<idno type="wicri:Area/Main/Exploration">00A896</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema</title>
<author>
<name sortKey="Karkkainen, M J" sort="Karkkainen, M J" uniqKey="Karkkainen M" first="M. J." last="Karkkainen">M. J. Karkkainen</name>
<affiliation wicri:level="4">
<inist:fA14 i1="01">
<s1>Molecular/Cancer Biology Laboratory, Ludwig Institute for Cancer Research, Huartman Institute, University of Helsinki</s1>
<s2>Helsinki</s2>
<s3>FIN</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Finlande</country>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
<orgName type="university">Université d'Helsinki</orgName>
</affiliation>
</author>
<author>
<name sortKey="Ferrell, R E" sort="Ferrell, R E" uniqKey="Ferrell R" first="R. E." last="Ferrell">R. E. Ferrell</name>
<affiliation wicri:level="4">
<inist:fA14 i1="02">
<s1>Department of Human Genetics, University of Pittsburgh</s1>
<s2>Pittsburgh, Penusylvania</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Pittsburgh</settlement>
<region type="state">Pennsylvanie</region>
</placeName>
<orgName type="university">Université de Pittsburgh</orgName>
</affiliation>
</author>
<author>
<name sortKey="Lawrence, E C" sort="Lawrence, E C" uniqKey="Lawrence E" first="E. C." last="Lawrence">E. C. Lawrence</name>
<affiliation wicri:level="4">
<inist:fA14 i1="02">
<s1>Department of Human Genetics, University of Pittsburgh</s1>
<s2>Pittsburgh, Penusylvania</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Pittsburgh</settlement>
<region type="state">Pennsylvanie</region>
</placeName>
<orgName type="university">Université de Pittsburgh</orgName>
</affiliation>
</author>
<author>
<name sortKey="Kimak, M A" sort="Kimak, M A" uniqKey="Kimak M" first="M. A." last="Kimak">M. A. Kimak</name>
<affiliation wicri:level="4">
<inist:fA14 i1="02">
<s1>Department of Human Genetics, University of Pittsburgh</s1>
<s2>Pittsburgh, Penusylvania</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Pittsburgh</settlement>
<region type="state">Pennsylvanie</region>
</placeName>
<orgName type="university">Université de Pittsburgh</orgName>
</affiliation>
</author>
<author>
<name sortKey="Levinson, K L" sort="Levinson, K L" uniqKey="Levinson K" first="K. L." last="Levinson">K. L. Levinson</name>
<affiliation wicri:level="4">
<inist:fA14 i1="02">
<s1>Department of Human Genetics, University of Pittsburgh</s1>
<s2>Pittsburgh, Penusylvania</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Pittsburgh</settlement>
<region type="state">Pennsylvanie</region>
</placeName>
<orgName type="university">Université de Pittsburgh</orgName>
</affiliation>
</author>
<author>
<name sortKey="Mctigue, M A" sort="Mctigue, M A" uniqKey="Mctigue M" first="M. A." last="Mctigue">M. A. Mctigue</name>
<affiliation wicri:level="2">
<inist:fA14 i1="03">
<s1>Agouron Pharmaceuticals, Inc.</s1>
<s2>San Diego, California</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Alitalo, K" sort="Alitalo, K" uniqKey="Alitalo K" first="K." last="Alitalo">Kari Alitalo</name>
<affiliation wicri:level="4">
<inist:fA14 i1="01">
<s1>Molecular/Cancer Biology Laboratory, Ludwig Institute for Cancer Research, Huartman Institute, University of Helsinki</s1>
<s2>Helsinki</s2>
<s3>FIN</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Finlande</country>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
<orgName type="university">Université d'Helsinki</orgName>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
<orgName type="university">Université d'Helsinki</orgName>
</affiliation>
</author>
<author>
<name sortKey="Finegold, D N" sort="Finegold, D N" uniqKey="Finegold D" first="D. N." last="Finegold">D. N. Finegold</name>
<affiliation wicri:level="4">
<inist:fA14 i1="02">
<s1>Department of Human Genetics, University of Pittsburgh</s1>
<s2>Pittsburgh, Penusylvania</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Pittsburgh</settlement>
<region type="state">Pennsylvanie</region>
</placeName>
<orgName type="university">Université de Pittsburgh</orgName>
</affiliation>
<affiliation wicri:level="4">
<inist:fA14 i1="04">
<s1>Department of Pediatrics, University of Pittsburgh</s1>
<s2>Pittsburgh, Penusylvania</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<settlement type="city">Pittsburgh</settlement>
<region type="state">Pennsylvanie</region>
</placeName>
<orgName type="university">Université de Pittsburgh</orgName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Nature genetics</title>
<title level="j" type="abbreviated">Nat. genet.</title>
<idno type="ISSN">1061-4036</idno>
<imprint>
<date when="2000">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Nature genetics</title>
<title level="j" type="abbreviated">Nat. genet.</title>
<idno type="ISSN">1061-4036</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Activation</term>
<term>Allele</term>
<term>Alleles</term>
<term>Animals</term>
<term>Biological receptor</term>
<term>Cell Line</term>
<term>Cell line</term>
<term>Chromosomes, Human, Pair 5 (genetics)</term>
<term>Endothelial Growth Factors (pharmacology)</term>
<term>Enzyme Stability</term>
<term>Family study</term>
<term>Female</term>
<term>Gene</term>
<term>Genes, Dominant (genetics)</term>
<term>Half-Life</term>
<term>Human</term>
<term>Humans</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Kidney</term>
<term>Lymphedema</term>
<term>Lymphedema (congenital)</term>
<term>Lymphedema (genetics)</term>
<term>Lymphedema (metabolism)</term>
<term>Male</term>
<term>Mice</term>
<term>Missense mutation</term>
<term>Models, Molecular</term>
<term>Molecular Sequence Data</term>
<term>Mutation, Missense (genetics)</term>
<term>Pedigree</term>
<term>Phosphorylation (drug effects)</term>
<term>Protein</term>
<term>Protein Structure, Secondary</term>
<term>Protein-tyrosine kinase</term>
<term>Receptor Protein-Tyrosine Kinases (chemistry)</term>
<term>Receptor Protein-Tyrosine Kinases (genetics)</term>
<term>Receptor Protein-Tyrosine Kinases (metabolism)</term>
<term>Receptors, Cell Surface (chemistry)</term>
<term>Receptors, Cell Surface (genetics)</term>
<term>Receptors, Cell Surface (metabolism)</term>
<term>Recombinant Fusion Proteins (chemistry)</term>
<term>Recombinant Fusion Proteins (genetics)</term>
<term>Recombinant Fusion Proteins (metabolism)</term>
<term>Regulation(control)</term>
<term>Signal Transduction (drug effects)</term>
<term>Signal transduction</term>
<term>Transcriptional Activation (drug effects)</term>
<term>Transcriptional Activation (genetics)</term>
<term>Vascular Endothelial Growth Factor C</term>
<term>Vascular Endothelial Growth Factor Receptor-3</term>
<term>Vascular endothelium growth factor</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Activation de la transcription ()</term>
<term>Activation de la transcription (génétique)</term>
<term>Allèles</term>
<term>Animaux</term>
<term>Chromosomes humains de la paire 5 (génétique)</term>
<term>Données de séquences moléculaires</term>
<term>Facteur de croissance endothéliale vasculaire de type C</term>
<term>Facteurs de croissance endothéliale (pharmacologie)</term>
<term>Femelle</term>
<term>Gènes dominants (génétique)</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Lymphoedème ()</term>
<term>Lymphoedème (génétique)</term>
<term>Lymphoedème (métabolisme)</term>
<term>Modèles moléculaires</term>
<term>Mutation faux-sens (génétique)</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Nouveau-né</term>
<term>Pedigree</term>
<term>Phosphorylation ()</term>
<term>Protéines de fusion recombinantes ()</term>
<term>Protéines de fusion recombinantes (génétique)</term>
<term>Protéines de fusion recombinantes (métabolisme)</term>
<term>Période</term>
<term>Récepteur-3 au facteur croissance endothéliale vasculaire</term>
<term>Récepteurs de surface cellulaire ()</term>
<term>Récepteurs de surface cellulaire (génétique)</term>
<term>Récepteurs de surface cellulaire (métabolisme)</term>
<term>Récepteurs à activité tyrosine kinase ()</term>
<term>Récepteurs à activité tyrosine kinase (génétique)</term>
<term>Récepteurs à activité tyrosine kinase (métabolisme)</term>
<term>Souris</term>
<term>Stabilité enzymatique</term>
<term>Structure secondaire des protéines</term>
<term>Transduction du signal ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Receptor Protein-Tyrosine Kinases</term>
<term>Receptors, Cell Surface</term>
<term>Recombinant Fusion Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Receptor Protein-Tyrosine Kinases</term>
<term>Receptors, Cell Surface</term>
<term>Recombinant Fusion Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Receptor Protein-Tyrosine Kinases</term>
<term>Receptors, Cell Surface</term>
<term>Recombinant Fusion Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Endothelial Growth Factors</term>
</keywords>
<keywords scheme="MESH" qualifier="congenital" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Phosphorylation</term>
<term>Signal Transduction</term>
<term>Transcriptional Activation</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Chromosomes, Human, Pair 5</term>
<term>Genes, Dominant</term>
<term>Lymphedema</term>
<term>Mutation, Missense</term>
<term>Transcriptional Activation</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Activation de la transcription</term>
<term>Chromosomes humains de la paire 5</term>
<term>Gènes dominants</term>
<term>Lymphoedème</term>
<term>Mutation faux-sens</term>
<term>Protéines de fusion recombinantes</term>
<term>Récepteurs de surface cellulaire</term>
<term>Récepteurs à activité tyrosine kinase</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Lymphoedème</term>
<term>Protéines de fusion recombinantes</term>
<term>Récepteurs de surface cellulaire</term>
<term>Récepteurs à activité tyrosine kinase</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Facteurs de croissance endothéliale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Alleles</term>
<term>Animals</term>
<term>Cell Line</term>
<term>Enzyme Stability</term>
<term>Female</term>
<term>Half-Life</term>
<term>Humans</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Male</term>
<term>Mice</term>
<term>Models, Molecular</term>
<term>Molecular Sequence Data</term>
<term>Pedigree</term>
<term>Protein Structure, Secondary</term>
<term>Vascular Endothelial Growth Factor C</term>
<term>Vascular Endothelial Growth Factor Receptor-3</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Activation de la transcription</term>
<term>Allèles</term>
<term>Animaux</term>
<term>Données de séquences moléculaires</term>
<term>Facteur de croissance endothéliale vasculaire de type C</term>
<term>Femelle</term>
<term>Homme</term>
<term>Etude familiale</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Lymphoedème</term>
<term>Modèles moléculaires</term>
<term>Mutation faux sens</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Nouveau-né</term>
<term>Pedigree</term>
<term>Phosphorylation</term>
<term>Protéines de fusion recombinantes</term>
<term>Période</term>
<term>Récepteur-3 au facteur croissance endothéliale vasculaire</term>
<term>Récepteurs de surface cellulaire</term>
<term>Récepteurs à activité tyrosine kinase</term>
<term>Souris</term>
<term>Stabilité enzymatique</term>
<term>Structure secondaire des protéines</term>
<term>Transduction du signal</term>
<term>Transduction signal</term>
<term>Facteur croissance endothélium vasculaire</term>
<term>Récepteur biologique</term>
<term>Allèle</term>
<term>Protéine</term>
<term>Protein-tyrosine kinase</term>
<term>Activation</term>
<term>Gène</term>
<term>Régulation</term>
<term>Lymphoedème</term>
<term>Rein</term>
<term>Lignée 293</term>
<term>VEGFR3</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Primary lymphoedema is a rare, autosomal dominant disorder that leads to a disabling and disfiguring swelling of the extremities and, when untreated, tends to worsen with time. Here we link primary human lymphoedema to the FLT4 locus, encoding vascular endothelial growth factor receptor-3 (VEGFR-3), in several families. All disease-associated alleles analysed had missense mutations and encoded proteins with an inactive tyrosine kinase, preventing downstream gene activation. Our study establishes that VEGFR-3 is important for normal lymphatic vascular function and that mutations interfering with VEGFR-3 signal transduction are a cause of primary lymphoedema.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Finlande</li>
<li>États-Unis</li>
</country>
<region>
<li>Californie</li>
<li>Pennsylvanie</li>
<li>Uusimaa</li>
</region>
<settlement>
<li>Helsinki</li>
<li>Pittsburgh</li>
</settlement>
<orgName>
<li>Université d'Helsinki</li>
<li>Université de Pittsburgh</li>
</orgName>
</list>
<tree>
<country name="Finlande">
<region name="Uusimaa">
<name sortKey="Karkkainen, M J" sort="Karkkainen, M J" uniqKey="Karkkainen M" first="M. J." last="Karkkainen">M. J. Karkkainen</name>
</region>
<name sortKey="Alitalo, K" sort="Alitalo, K" uniqKey="Alitalo K" first="K." last="Alitalo">Kari Alitalo</name>
</country>
<country name="États-Unis">
<region name="Pennsylvanie">
<name sortKey="Ferrell, R E" sort="Ferrell, R E" uniqKey="Ferrell R" first="R. E." last="Ferrell">R. E. Ferrell</name>
</region>
<name sortKey="Finegold, D N" sort="Finegold, D N" uniqKey="Finegold D" first="D. N." last="Finegold">D. N. Finegold</name>
<name sortKey="Finegold, D N" sort="Finegold, D N" uniqKey="Finegold D" first="D. N." last="Finegold">D. N. Finegold</name>
<name sortKey="Kimak, M A" sort="Kimak, M A" uniqKey="Kimak M" first="M. A." last="Kimak">M. A. Kimak</name>
<name sortKey="Lawrence, E C" sort="Lawrence, E C" uniqKey="Lawrence E" first="E. C." last="Lawrence">E. C. Lawrence</name>
<name sortKey="Levinson, K L" sort="Levinson, K L" uniqKey="Levinson K" first="K. L." last="Levinson">K. L. Levinson</name>
<name sortKey="Mctigue, M A" sort="Mctigue, M A" uniqKey="Mctigue M" first="M. A." last="Mctigue">M. A. Mctigue</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00A896 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00A896 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:00-0306799
   |texte=   Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024